{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T08:55:38Z","timestamp":1794300938680,"version":"4.9.0"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6S","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Glucagon-like peptide-1 (GLP) receptor agonists have demonstrated anti-inflammatory and wound-healing properties, but their impact on outcomes after dermatologic surgery has not been evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>This study assessed the one-month risk of postoperative inflammatory complications (IC) in patients taking GLPs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Patients undergoing Mohs Micrographic Surgery and wide local excisions for melanoma or nonmelanoma skin cancer while taking a GLP were identified using the TriNetx Research Network. GLPs included semaglutide, tirzepatide, liraglutide, dulaglutide, exenatide, albiglutide, and lixisenatide. IC included wound disruption, hematoma, infection of the skin and subcutaneous tissue, infections after a procedure, and other complications of procedures. After accounting for demographics and proinflammatory comorbid conditions, hazard ratios and 95% confidence intervals were used to identify the one-month risk of postoperative complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Compared with patients without GLP use, the GLP cohort was associated with a significantly reduced risk of infection after a procedure, wound disruption, skin and subcutaneous tissue infection, hematoma, and other complications. Among individual drug comparisons, semaglutide and tirzepatide demonstrated the greatest reductions in postoperative complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>GLP receptor agonists were associated with a significantly reduced risk of postoperative inflammatory complications after dermatologic surgery, supporting their perioperative safety and potential beneficial role in wound healing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000005162","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:00:33Z","timestamp":1780045233000},"page":"S35-S38","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["GLPs Significantly Decrease the Risk of Postoperative Surgical Complications: A TriNetX Retrospective Cohort Study"],"prefix":"10.1097","volume":"52","author":[{"given":"Marie","family":"Vu","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Texas Medical Branch, Galveston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelyn","family":"Schmidt","sequence":"additional","affiliation":[{"name":"John Sealy School of Medicine, Galveston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smiti","family":"Gandhi","sequence":"additional","affiliation":[{"name":"John Sealy School of Medicine, Galveston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Texas Medical Branch, Galveston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"R1-20260730","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1016\/j.jid.2025.08.045","article-title":"GLP-1 receptor agonists as emerging modulators of inflammation and angiogenesis in chronic cutaneous wound healing","volume":"145","author":"Ghebrehiwet-Kuflom","year":"2025","journal-title":"J Invest Dermatol"},{"key":"R2-20260730","doi-asserted-by":"crossref","first-page":"14791641251322909","DOI":"10.1177\/14791641251322909","article-title":"The impact of semaglutide on wound healing in diabetes related foot ulcer patients: a TriNetX database study","volume":"22","author":"Lewis","year":"2025","journal-title":"Diab Vasc Dis Res"},{"key":"R3-20260730","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1007\/s12325-025-03257-w","article-title":"GLP-1 receptor agonists, DPP-4 inhibitors and the skin-diabetes meets dermatology: a brief narrative review","volume":"42","author":"Pantazopoulos","year":"2025","journal-title":"Adv Ther"},{"key":"R4-20260730","first-page":"42","article-title":"A review of Glucagon-like Peptide-1 in dermatology","volume":"18","author":"Patino","year":"2025","journal-title":"J Clin Aesthet Dermatol"},{"key":"R5-20260730","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1007\/s13555-025-01537-5","article-title":"Benefit-risk assessment of GLP-1 receptor agonists: implications for dermatologists and plastic surgeons","volume":"15","author":"Cedirian","year":"2025","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DSS.0000000000005162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:02:34Z","timestamp":1785384154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/DSS.0000000000005162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":5,"journal-issue":{"issue":"6S","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000005162","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]}}}